Pacific Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Pacific Capital Partners's WST Position: Q3 2026 in Review
Pacific Capital Partners reduced its West Pharmaceutical (WST) stake by 32% in Q3 2026, selling an estimated $414K and leaving 2,527 shares worth $937K. The position accounts for 0.71% of the portfolio, ranked #36.
Pacific Capital Partners first reported a position in WST in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.33M in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Pacific Capital Partners held 2,527 shares of West Pharmaceutical worth $937K as of Q3 2026.
- Pacific Capital Partners sold 1,173 West Pharmaceutical shares in Q3 2026, an estimated $414K.
- West Pharmaceutical made up 0.71% of Pacific Capital Partners's portfolio in Q3 2026, its #36 holding.
- Pacific Capital Partners first reported a position in West Pharmaceutical in Q2 2026 and has held it in 2 quarters since.
- Pacific Capital Partners's West Pharmaceutical position peaked at $1.33M in Q2 2026.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Pacific Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.